LEADER 03622namaa2200901uu 4500
001 doab96708
003 oapen
005 20230202
006 m o d
007 cr|mn|---annan
008 230202s2023 xx |||||o ||| 0|eng d
020 |a 9783036563381 
020 |a 9783036563398 
020 |a books978-3-0365-6339-8 
024 7 |a 10.3390/books978-3-0365-6339-8  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
720 1 |a Ridola, Lorenzo  |4 edt 
720 1 |a Ridola, Lorenzo  |4 oth 
720 1 |a Riggio, Oliviero  |4 edt 
720 1 |a Riggio, Oliviero  |4 oth 
245 0 0 |a Hepatic Encephalopathy  |b Clinical Challenges and Opportunities 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 online resource (160 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a Hepatic encephalopathy (HE) is a complex neurological syndrome, characteristic of patients with liver disease, that causes a wide and complex spectrum of nonspecific neurological and psychiatric manifestations, ranging from a subclinical entity such as minimal or covert hepatic encephalopathy to a deep form in which a complete alteration of consciousness can be observed: overt hepatic encephalopathy. Both minimal and overt hepatic encephalopathy have a high impact on patients, caregivers, and national health services, driving substantial consumption of economic resources. In this Special Issue, we discussed the current state-of-the-art research, address ongoing knowledge gaps, and ongoing controversies related to the pathogenesis, diagnosis, and therapeutic management of hepatic encephalopathy. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a antibiotic resistance 
653 |a autonomic testing 
653 |a bile acids 
653 |a brain energy crisis 
653 |a capsules 
653 |a cirrhosis 
653 |a cognitive function 
653 |a coma 
653 |a delirium 
653 |a dietary intervention 
653 |a encephalopathy 
653 |a enema 
653 |a epidemiology 
653 |a gluconeogenesis 
653 |a hepatic encephalopathy 
653 |a hospitalizations 
653 |a hyperammonemia 
653 |a idiopathic non-cirrhotic portal hypertension 
653 |a ketogenesis 
653 |a liver 
653 |a liver cirrhosis 
653 |a liver disease 
653 |a liver failure 
653 |a minimal hepatic encephalopathy 
653 |a mitochondria 
653 |a mortality 
653 |a myosteatosis 
653 |a n/a 
653 |a nerve conduction 
653 |a non-absorbable disaccharides 
653 |a portal vein thrombosis 
653 |a porto-sinusoidal vascular liver disease 
653 |a porto-systemic shunt 
653 |a protein caloric-malnutrition 
653 |a quality of life 
653 |a rifaximin 
653 |a sarcopenia 
653 |a sleep disorders 
653 |a therapy 
653 |a thermal sensitivity 
653 |a transjugular portosystemic intrahepatic shunt 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/96708  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/6654  |7 0  |z Open Access: DOAB, download the publication